XRF Scientific Future Growth

Future criteria checks 3/6

XRF Scientific is forecast to grow earnings and revenue by 12.3% and 8.9% per annum respectively. EPS is expected to grow by 11.8% per annum. Return on equity is forecast to be 18% in 3 years.

Key information

12.3%

Earnings growth rate

11.8%

EPS growth rate

Machinery earnings growth25.7%
Revenue growth rate8.9%
Future return on equity18.0%
Analyst coverage

Low

Last updated18 Feb 2025

Recent future growth updates

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21
Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Recent updates

Here's Why We Think XRF Scientific (ASX:XRF) Is Well Worth Watching

Feb 18
Here's Why We Think XRF Scientific (ASX:XRF) Is Well Worth Watching

Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly

Nov 13
Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21
Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

May 24
XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Feb 12
Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

Jan 18
Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05
Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

Sep 19
XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28
XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Aug 22
Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Feb 01
Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Oct 19
XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

May 12
We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Apr 21
XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Oct 01
Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

May 18
XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

Apr 19
Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17
An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01
XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17
Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27
Our View On XRF Scientific's (ASX:XRF) CEO Pay

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12
Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23
XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10
XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25
The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Earnings and Revenue Growth Forecasts

ASX:XRF - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2027741312131
6/30/2026671211131
6/30/202561109121
12/31/2024609910N/A
9/30/202460989N/A
6/30/202460968N/A
3/31/202458978N/A
12/31/202357878N/A
9/30/202356878N/A
6/30/202355888N/A
3/31/202352756N/A
12/31/202249734N/A
9/30/202244733N/A
6/30/202240633N/A
3/31/202237634N/A
12/31/202135645N/A
9/30/202133545N/A
6/30/202131545N/A
3/31/202130545N/A
12/31/202028455N/A
9/30/202029345N/A
6/30/202029334N/A
3/31/202029334N/A
12/31/201930323N/A
9/30/201929233N/A
6/30/201929234N/A
3/31/201928222N/A
12/31/201827201N/A
9/30/2018261N/A1N/A
6/30/2018241N/A1N/A
3/31/2018241N/A1N/A
12/31/2017231N/A1N/A
9/30/2017221N/A0N/A
6/30/2017221N/A0N/A
3/31/2017221N/A1N/A
12/31/2016221N/A1N/A
9/30/2016211N/A1N/A
6/30/2016212N/A0N/A
3/31/2016202N/A1N/A
12/31/2015202N/A2N/A
9/30/2015202N/A3N/A
6/30/2015213N/A4N/A
3/31/2015213N/A4N/A
12/31/2014223N/A3N/A
9/30/2014223N/A3N/A
6/30/2014222N/A3N/A
3/31/2014213N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: XRF's forecast earnings growth (12.3% per year) is above the savings rate (2.7%).

Earnings vs Market: XRF's earnings (12.3% per year) are forecast to grow faster than the Australian market (12% per year).

High Growth Earnings: XRF's earnings are forecast to grow, but not significantly.

Revenue vs Market: XRF's revenue (8.9% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: XRF's revenue (8.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: XRF's Return on Equity is forecast to be low in 3 years time (18%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 22:41
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

XRF Scientific Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cameron BellCanaccord Genuity